About Biocoll Pharmaceuticals
Biocoll Pharmaceuticals manufactures and exports pharmaceutical products and pet medications through providing healthcare solutions, producing pharmaceutical products, manufacturing and export, and pet medications. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarter Delhi, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Biocoll Pharmaceuticals Private Limited
- Date of Incorporation 18 Apr, 2015
- Jurisdiction Delhi, Delhi, India
-
Annual Revenue
$753.52 K (USD)-44as on Mar 31, 2023
-
Net Profit
$14.98 K (USD)-48.1as on Mar 31, 2023
-
EBITDA
$16.55 K (USD)-45.81as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biocoll Pharmaceuticals
Detailed funding history for Biocoll Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocoll Pharmaceuticals
Investment portfolio details for Biocoll Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biocoll Pharmaceuticals
Detailed financials for Biocoll Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocoll Pharmaceuticals Comparisons
Peer comparison for Biocoll Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocoll Pharmaceuticals
Detailed competitors of Biocoll Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocoll Pharmaceuticals
Complete news archive for Biocoll Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocoll Pharmaceuticals
Biocoll Pharmaceuticals was founded in 2004.
Biocoll Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Annual revenue of Biocoll Pharmaceuticals is $753.52K as on Mar 31, 2023.
Biocoll Pharmaceuticals manufactures and exports pharmaceutical products and pet medications through providing healthcare solutions, producing pharmaceutical products, manufacturing and export, and pet medications. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.